NYT:NYSENew York Times Company (The) Analysis
Data as of 2026-07-05 - not real-time
$73.85
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
The New York Times is trading well above its discounted cash‑flow estimate, with the market price roughly double the industry’s average price‑to‑earnings multiple, suggesting a premium valuation. Revenue growth of about 12% YoY and stable profit margins around 13% underline solid operating performance, while a cash‑rich balance sheet (no debt and a healthy cash balance) supports the declared dividend. The board’s recent affirmation of a $0.23 quarterly payout translates to a modest 1.25% yield and a payout ratio near 40%, indicating dividend sustainability. Technicals are mixed: the 20‑day SMA sits just below price, the MACD histogram is positive and the RSI hovers near the midpoint, pointing to a neutral‑to‑slightly‑bullish short‑term bias, and volume is trending upward. However, 30‑day volatility is near 27% and the stock sits close to its identified resistance around $77, limiting immediate upside.
Looking ahead, analysts project upside of roughly 14% versus the DCF fair value, and the consensus target median of $88 implies further room for price appreciation. The company’s diversified digital offerings, strong brand moat, and consistent cash flow generation bolster a longer‑term growth narrative, but the current premium valuation tempers expectations. Investors should weigh the attractive dividend and growth fundamentals against the elevated price and sector‑specific risks before deciding on positioning.
Looking ahead, analysts project upside of roughly 14% versus the DCF fair value, and the consensus target median of $88 implies further room for price appreciation. The company’s diversified digital offerings, strong brand moat, and consistent cash flow generation bolster a longer‑term growth narrative, but the current premium valuation tempers expectations. Investors should weigh the attractive dividend and growth fundamentals against the elevated price and sector‑specific risks before deciding on positioning.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Neutral technical trend with slight bullish MACD histogram
- Recent dividend affirmation supporting income appeal
- Price approaching identified resistance level
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Consistent revenue and earnings growth
- Sustainable dividend with low payout ratio
- Upside potential relative to DCF fair value and analyst targets
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Strong brand moat and diversified digital portfolio
- Robust cash generation and zero‑debt balance sheet
- Long‑term earnings growth underpinning dividend sustainability
Key Metrics & Analysis
Financial Health
Revenue Growth12.10%
Profit Margin13.30%
P/E Ratio31.7
ROE19.68%
ROA10.24%
Debt/Equity2.39
P/B Ratio5.9
Op. Cash Flow$577.6M
Free Cash Flow$390.8M
Industry P/E16.7
Technical Analysis
TrendNeutral
RSI51.7
Support$68.52
Resistance$77.04
MA 20$72.87
MA 50$75.54
MA 200$70.73
MACDBullish
VolumeIncreasing
Fear & Greed Index93.2
Valuation
Fair Value$56.55
Target Price$84.11
Upside/Downside13.89%
GradeOvervalued
TypeGrowth
Dividend Yield1.25%
Risk Assessment
Beta0.21
Volatility26.89%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.